EGR3 and prostate carcinoma: This expression pattern: low Egr3 mRNA in normal prostate versus high expression in cancer, and distinction between relapse and non-relapse, was confirmed with the independent prostate cancer gene expression dataset from the University of Pittsburg [26]–[28].